Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05056857

Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen

Neutrophil Functions in Breast Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
290 (estimated)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This study examines the long-term effects of tamoxifen (TAM) treatment on excessive production of neutrophil extracellular traps (NET) and their impact on breast cancer and side effects. NET are produced by the body to fight infections but have also been linked to side effects caused by the body's immune system. Treatment with tamoxifen increases the production of NETs. This study may help researchers determine if the increased number of NETs in the body has a damaging effect in breast cancer.

Detailed description

PRIMARY OBJECTIVE: I. To examine the effect of long-term tamoxifen (TAM) treatment on excessive NET formation in breast cancer patients. SECONDARY OBJECTIVES: I. To understand the molecular mechanisms of tamoxifen-induced NET formation in breast cancer patients by examining the effect of long-term TAM treatment on the NET-induced factors. II. To correlate the extend of NET formation with clinical data on tamoxifen resistance, drug side-effects, cancer metastasis and comorbidities. EXPLORATORY OBJECTIVE: I. To explore the association between the extent of NET formation and clinical data for breast cancer patients treated with TAM in combination with other drugs. OUTLINE: Patients undergo collection of blood samples and their medical charts are reviewed.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionUndergo collection of blood sample
OTHERElectronic Health Record ReviewMedical charts are reviewed

Timeline

Start date
2021-10-01
Primary completion
2026-10-31
Completion
2026-10-31
First posted
2021-09-27
Last updated
2025-12-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05056857. Inclusion in this directory is not an endorsement.